Hecht, J. R., Michot, J., Bajor, D., Patnaik, A., Chung, K. Y., Wang, J., . . . Ulahannan, S. CITRINO: Phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours. Nature Portfolio.
Chicago Style (17th ed.) CitationHecht, J. Randolph, et al. CITRINO: Phase 1 Dose Escalation Study of Anti-LAG-3 Antibody Encelimab Alone or in Combination with Anti-PD-1 Dostarlimab in Patients with Advanced/metastatic Solid Tumours. Nature Portfolio.
MLA (9th ed.) CitationHecht, J. Randolph, et al. CITRINO: Phase 1 Dose Escalation Study of Anti-LAG-3 Antibody Encelimab Alone or in Combination with Anti-PD-1 Dostarlimab in Patients with Advanced/metastatic Solid Tumours. Nature Portfolio.